Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma
Authors
Keywords
Cancer, Melanoma, Immunotherapy, Allotransplant, Rejection, T-VEC
Journal
Journal for ImmunoTherapy of Cancer
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-25
DOI
10.1186/s40425-017-0250-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy
- (2016) C. L. Boils et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection
- (2016) T. Alhamad et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma
- (2016) L. Spain et al. ANNALS OF ONCOLOGY
- Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report
- (2016) Taofeek K. Owonikoko et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Regression and Allograft Rejection after Administration of Anti–PD-1
- (2016) Evan J. Lipson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Administration of Ipilimumab to a Liver Transplant Recipient With Unresectable Metastatic Melanoma
- (2015) Harsha A. Ranganath et al. JOURNAL OF IMMUNOTHERAPY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation
- (2015) Rita E Morales et al. Journal for ImmunoTherapy of Cancer
- New Perspectives on the Role of Vitiligo in Immune Responses to Melanoma
- (2015) Katelyn T. Byrne et al. Oncotarget
- Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma
- (2014) Evan J. Lipson et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanoma in Solid Organ Transplant Recipients
- (2010) F. O. Zwald et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review
- (2009) P. Dillon et al. MEDICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started